Angiogenesis Using Recombinant Basic Fibroblast Growth Factor With Atelocollagen in Normal and Hind Limb Ischemia Models
Intramuscular administration of recombinant bFGF with atelocollagen induced angiogenesis between 2 and 4 weeks in both normal and ischemic hind limbs.
Authors
- Shin Watanabe (ORCID: https://orcid.org/0000-0001-8526-3712)
- Katsuhiko Hori
- Jun Yoshimura (ORCID: https://orcid.org/0000-0003-2988-1123)
- Atsushi Kotani
- Takayuki Kikuchi (ORCID: https://orcid.org/0000-0003-0588-2172)
- Takao Kato (ORCID: https://orcid.org/0000-0001-8213-7999)
- Keiji Toya
- Kenji Yanishi (ORCID: https://orcid.org/0000-0002-6158-9395)
- Hirofumi Kawamata (ORCID: https://orcid.org/0000-0002-5404-7432)
- Yoji Nagai (ORCID: https://orcid.org/0000-0002-0836-0495)
- Yasuko Kimura
- Satoaki Matoba
- Noriko Minobe
- Kaori Musumi
Institutions
- Kyoto University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Kyoto University Hospital (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1253/circrep.cr-25-0011
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00